Carbadox,
Fortrigo,
Getroxel,
Mecadox,
CARBADOX,
6804-07-5,
Getroxel,
Mecadox,
MLS001333201,
MFCD00057293,
SMR000857182,
DSSTox_CID_23913,
DSSTox_RID_80088,
DSSTox_GSID_43913,
Fortigro,
W-104691,
C11H10N4O4,
Fortrigo,
Karbadox [Czech],
methyl N-[(E)-(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methyl]iminocarbamate,
N-[(E)-(1-hydroxy-4-oxido-quinoxalin-4-ium-2-ylidene)methyl]iminocarbamic acid methyl ester,
CAS-6804-07-5,
Carbadoxum [INN-Latin],
Carbadox [USAN:INN:BAN],
SR-05000001715,
CCRIS 3002,
HSDB 7028,
EINECS 229-879-0,
3-(2-Quinoxalinylmethylene)carbazic acid methyl ester N,N'-dioxide,
N-[(1E)-2-(1,4-dihydroxyquinoxalin-2-yl)-1-azavinyl]methoxycarboxamide,
GS 6244,
GS-6244,
AC1L1DXQ,
AC1NSEG1,
2-Formylquinoxaline 1,4-dioxide carbomethoxyhydrazone,
AC1NS48Y,
Methyl 3-(2-quinoxalinylmethylene)carbazate-N1,N4-dioxide,
BSPBio_003554,
3-(2-Chinoxalinylmethylen-1,4-dioxid)methylkarbazat [Czech],
MLS001333202,
CHEMBL13779,
SCHEMBL193112,
SPECTRUM1505294,
(E)-2-((2-(methoxycarbonyl)hydrazono)methyl)quinoxaline 1,4-dioxide,
DTXSID6043913,
Methyl 3-(2-quinoxalinylmethylene)carbazate N(sup 1),N(sup 4)-dioxide,
SCHEMBL14973511,
BDBM58923,
CHEBI:94744,
cid_5353472,
Carbazic acid, 3-(2-quinoxalinylmethylene)-, methyl ester, N(sup 1),N(sup 4)-dioxide,
Hydrazinecarboxylic acid (2-quinoxalinylmethylene)-, methyl ester N(sup 1),N(sup 4)-dioxide,
HMS1922B06,
HMS2090M03,
HMS2093O20,
HMS3713J12,
Pharmakon1600-01505294,
HY-B1340,
Hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester N(sup 1),N(sup 4)-dioxide,
Tox21_111456,
CCG-39539,
DL-343,
NSC758942,
SBB058137,
AKOS015895709,
AKOS026749942,
Tox21_111456_1,
API0001841,
CS-8210,
NSC-758942,
Hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester, N,N'-dioxide,
NCGC00095156-03,
NCGC00095156-06,
AC-11698,
AN-21280,
BC203170,
LS-51665,
TR-022784,
ST51014956,
AB01275499-01,
AB01275499_02,
AB01275499_03,
A835985,
SR-05000001715-1,
SR-05000001715-3,
BRD-K56735750-001-03-5,
3-[2-Quinoxalinylmethylene]carbazic acid methyl ester-N,N'-dioxide,
Methyl (2E)-2-[(1,4-dioxido-2-quinoxalinyl)methylene]hydrazinecarboxylate,
2-({[(methoxycarbonyl)amino]imino}methyl)quinoxaline-1,4-diium-1,4-bis(olate),
3-({[(methoxycarbonyl)amino]imino}methyl)quinoxaline-1,4-diium-1,4-bis(olate),
Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-,methyl ester,
methyl N-[(1-hydroxy-4-oxido-quinoxalin-4-ium-2-ylidene)methylimino]carbamate,
methyl N-[(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methylimino]carbamate,
methyl N-[(4-oxidanidyl-1-oxidanyl-quinoxalin-4-ium-2-ylidene)methylimino]carbamate,
methyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate,
methyl N-[(E)-(4-oxidanidyl-1-oxidanyl-quinoxalin-4-ium-2-ylidene)methyl]iminocarbamate,
methyl N-[(Z)-(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methyl]iminocarbamate,
N-[(1-hydroxy-4-oxido-2-quinoxalin-4-iumylidene)methylimino]carbamic acid methyl ester,
N-[(E)-(1-hydroxy-4-oxido-2-quinoxalin-4-iumylidene)methyl]iminocarbamic acid methyl ester,
CID2553,
MFCD00963621,
TRANS-PHENYLETHENYLBORONIC ACID,
CID5353472,
CID5360219,
NCGC00095156-01,
A8388,
D002218,
Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-, methyl ester,